News and Events

News

All categories

Earnings

Press Release

All years

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

Affimed Announces Acceptance of Abstracts at the 17th International Conference on Malignant Lymphoma (17-ICML)

June 9, 2023

Affimed Presents AFM24 Monotherapy Data in Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology and Provides Strategic Update on AFM24 Development Plan

June 3, 2023

Affimed Presents AFM24 Monotherapy Data in Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology and Provides Strategic Update on AFM24 Development Plan

June 3, 2023

Affimed to Present at the 2023 Jefferies Healthcare Conference

May 30, 2023

Affimed Announces Publication of AFM24 Clinical Abstracts for the Annual Meeting of the American Society of Clinical Oncology

May 25, 2023

Affimed Reports First Quarter 2023 Financial Results and Highlights Operational Progress

May 23, 2023

Affimed Announces IND Clearance for a Phase 2 Clinical Trial Investigating AFM13 and AB-101 Combination Therapy

May 23, 2023

Affimed Announces Annual General Meeting of Shareholders

May 22, 2023

Affimed to Report First Quarter 2023 Financial Results & Corporate Update on May 23, 2023

May 16, 2023

Affimed Announces Abstracts at the Annual Meeting of the European Hematology Association

May 11, 2023

Events

All

Scientific

Investors

There are no events planned at the moment.

Webcasts More events

News and Events

News and Events

See what’s new at Affimed

See what’s new at Affimed

News

Affimed Announces Acceptance of Abstracts at the 17th International Conference on Malignant Lymphoma (17-ICML)

Affimed Presents AFM24 Monotherapy Data in Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology and Provides Strategic Update on AFM24 Development Plan

Affimed Presents AFM24 Monotherapy Data in Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology and Provides Strategic Update on AFM24 Development Plan

Affimed to Present at the 2023 Jefferies Healthcare Conference

Affimed Announces Publication of AFM24 Clinical Abstracts for the Annual Meeting of the American Society of Clinical Oncology

Affimed Reports First Quarter 2023 Financial Results and Highlights Operational Progress

Affimed Announces IND Clearance for a Phase 2 Clinical Trial Investigating AFM13 and AB-101 Combination Therapy

Affimed Announces Annual General Meeting of Shareholders

Affimed to Report First Quarter 2023 Financial Results & Corporate Update on May 23, 2023

Affimed Announces Abstracts at the Annual Meeting of the European Hematology Association

Events